Characteristics and Factors Associated With the Clinical Forms of Lipoatrophy During Highly Active Antiretroviral Therapy in Ouagadougou, Burkina Faso

Oumar Guira, MD; Hervé Tiéno, MD; Bertille Yaméogo, MD; Arnaud Eric Diendéré, MD; Nina Korsaga, MD; Yempabou Sagna, MD; Lassané Zoungrana, MD; Ismael Diallo, MD; René Traoré, MD; Joseph Youssouf Drabo, MD


J Int Assoc Provid AIDS Care. 2014;13(2):184-187. 

In This Article


Lipoatrophy during HAART is not uncommon. Regardless of whether lipoatrophy appears isolated or as part of a mixed syndrome, it deserves more attention in terms of prevention and care. In Burkina Faso, removal of d4T in HAART regimens is an important step in this direction. Later in subsequent studies, it would be pertinent to assess the association of lipoatrophy with cardiovascular risk factors and its psychological impact.